Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Strides Pharma Science Financial Results

Strides Pharma reported audited FY26 results and recommended a 50% final dividend. The proposed payout will result in an approximate cash outflow of ₹46.10 Crore.

Key figures
Value₹461.0 Cr
Source

BSE filing, NSE: STAR. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Strides Pharma Science Ltd: key numbers

Share price
₹1,085.60
Market cap
₹10,006 Cr
Revenue (annual)
₹4,859 Cr
Net profit (annual)
₹556.2 Cr
P/E (TTM)
16.3×Sector 46.1×
Promoter holding
29.00%+1.09% QoQ
FII holding
27.98%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Strides Pharma Science Ltd

All →

Other financial results announcements

All →